LabGenomics plans to buy 4 to 5 more CLIA labs in US by 2027

LabGenomics Co. will advance into the US diagnostics market with laboratories regulated by the country’s Clinical Laboratory Improvement Amend...
LabGenomics Co. will advance into the US diagnostics market with laboratories regulated by the country’s Clinical Laboratory Improvement Amend...
Bertis, a company specializing in the development of proteomics-based precision medicine technology , announced on Monday the launch of PASS (Pan-om...
The US operations of South Korea's artificial intelligence (AI) medical company Lunit have received a major boost after the company got the green li...